Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.

Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS.

Mol Endocrinol. 2008 Sep;22(9):2116-27. doi: 10.1210/me.2008-0059.

PMID:
18617595
2.

In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro.

Otto C, Fuchs I, Altmann H, Klewer M, Schwarz G, Bohlmann R, Nguyen D, Zorn L, Vonk R, Prelle K, Osterman T, Malmström C, Fritzemeier KH.

J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):95-100. doi: 10.1016/j.jsbmb.2008.05.003.

PMID:
18606537
3.

Intimal hyperplasia in murine models.

Hui DY.

Curr Drug Targets. 2008 Mar;9(3):251-60. Review.

PMID:
18336244
4.

Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI.

Zhao D, Richer E, Antich PP, Mason RP.

FASEB J. 2008 Jul;22(7):2445-51. doi: 10.1096/fj.07-103713.

PMID:
18263704
5.

Extranuclear steroid receptors: nature and actions.

Hammes SR, Levin ER.

Endocr Rev. 2007 Dec;28(7):726-41. Review.

PMID:
17916740
6.

27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.

Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ.

Nat Med. 2007 Oct;13(10):1185-92.

PMID:
17873880
7.
8.

In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.

Xu R, Wang Y, Wang X, Jeong EK, Parker DL, Lu ZR.

Exp Biol Med (Maywood). 2007 Sep;232(8):1081-9.

PMID:
17720954
9.

Estrogen receptors outside the nucleus in breast cancer.

Levin ER, Pietras RJ.

Breast Cancer Res Treat. 2008 Apr;108(3):351-61. Review.

PMID:
17592774
10.
11.

Estrogen therapy and coronary-artery calcification.

Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML; WHI and WHI-CACS Investigators..

N Engl J Med. 2007 Jun 21;356(25):2591-602.

PMID:
17582069
12.

A conserved mechanism for steroid receptor translocation to the plasma membrane.

Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER.

J Biol Chem. 2007 Aug 3;282(31):22278-88.

PMID:
17535799
13.

Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α .

Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG, Shaul PW.

Mol Endocrinol. 2007 Jun;21(6):1370-80.

PMID:
17405905
14.
15.

Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptors.

Kim SH, Katzenellenbogen JA.

Angew Chem Int Ed Engl. 2006 Nov 6;45(43):7243-8. No abstract available.

PMID:
17024710
16.

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR Jr.

Bioconjug Chem. 2006 Sep-Oct;17(5):1109-15.

PMID:
16984117
17.

Minireview: estrogen receptor-mediated rapid signaling.

Moriarty K, Kim KH, Bender JR.

Endocrinology. 2006 Dec;147(12):5557-63. Review.

PMID:
16946015
18.

The dynamics of estrogen receptor activity.

Ciana P, Scarlatti F, Biserni A, Ottobrini L, Brena A, Lana A, Zagari F, Lucignani G, Maggi A.

Maturitas. 2006 Jul 20;54(4):315-20. Review.

PMID:
16753274
19.

Nature of functional estrogen receptors at the plasma membrane.

Pedram A, Razandi M, Levin ER.

Mol Endocrinol. 2006 Sep;20(9):1996-2009.

PMID:
16645038
20.

Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways.

Bookout AL, Mangelsdorf DJ.

Nucl Recept Signal. 2003;1:e012.

PMID:
16604184
Items per page

Supplemental Content

Support Center